Esta galería contiene 1 foto.
The global economy is once again facing two sources of uncertainty that, although different in origin, could reinforce one another. On the one hand, the Trump administration has approved a new package of tariffs on US imports. On the other, the crisis in the Strait of Hormuz continues to disrupt the transportation of oil and gas from the Persian Gulf. Sigue leyendo
Pharmas are increasingly outsourcing R&D to CROs to expedite drug development and reduce costs. The model is working well so far, as the fast production of the Covid-19 vaccine showed. CROs perform their tasks efficiently and are growing in number, size and scope. There are, however, important risks in this strategy which should be considered. Understanding this unique model is enriching not only for the pharma industry but also for those interested in the generation of new knowledge and in outsourcing. Sigue leyendo